Related references
Note: Only part of the references are listed.Pharmacokinetics of polymyxin B1 in patients with multidrug-resistant Gram-negative bacterial infections
Andrea L. H. Kwa et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2008)
Continuous versus intermittent infusion of polymyxin B in the treatment of infections caused by multidrug-resistant Gram-negative bacteria
Christine B. Teng et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2008)
Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review
Alexandre Prehn Zavascki et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea
Kwan Soo Ko et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Polymyxin B: similarities to and differences from colistin (polymyxin E)
Andrea Kwa et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2007)
Intravenous polymyxin B for the treatment of nosocomial pneumonia caused by multidrug-resistant Pseudomonas aeruginosa
Guilherme Henrique Campos Furtado et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Salvage treatment of pneumonia and initial treatment of tracheobronchitis caused by multidrug-resistant Gram-negative bacilli with inhaled polymyxin B
Graziella H. Pereira et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2007)
When to include polymyxins, in the empirical antibiotic regimen in critically ill patients with fever? A decision analysis approach
Matthew E. Falagas et al.
SHOCK (2007)
Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review
Dinna N. Cruz et al.
CRITICAL CARE (2007)
Intraventricular or intrathecal use of polymyxins in patients with Gram-negative meningitis: a systematic review of the available evidence
Matthew E. Falagas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Prophylactic intravenous immune globulin and polymixin B decrease the incidence of septic episodes and hospital length of stay in severely burned children
Jefferson M. Lyons et al.
JOURNAL OF BURN CARE & RESEARCH (2006)
Polymyxin B and doxycycline use in patients with multidrug-resistant Acinetobacter baumannii infections in the intensive care unit
Katherine P. Holloway et al.
ANNALS OF PHARMACOTHERAPY (2006)
A novel role for protein-tyrosine kinase Etk from Escherichia coli K-12 related to polymyxin resistance
Soline Lacour et al.
RESEARCH IN MICROBIOLOGY (2006)
Multidrug-resistant Pseudomonas aeruginosa infection in neutropenic patients successfully treated with a combination of polymyxin B and rifampin
M. Ostronoff et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2006)
Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004)
AC Gales et al.
CLINICAL MICROBIOLOGY AND INFECTION (2006)
Toxicity of polymyxins: a systematic review of the evidence from old and recent studies
Matthew E. Falagas et al.
CRITICAL CARE (2006)
Development and comparative anti-microbial evaluation of lipid nanoparticles and nanoemulsion of polymyxin B
A. S. Pattani et al.
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY (2006)
The Use of Intravenous and Aerosolized Polymyxins for the Treatment of Infections in Critically III Patients: A Review of the Recent Literature
Matthew E. Falagas et al.
CLINICAL MEDICINE & RESEARCH (2006)
Extended spectrum β-lactamase-producing Klebsiella pneumoniae chronic ambulatory peritoneal dialysis peritonitis treated successfully with polymyxin B
S Parchuri et al.
HEART & LUNG (2005)
Pharmacodynamics of polymyxin B against Pseudomonas aeruginosa
VH Tam et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Citywide emergence of Pseudomonas aeruginosa strains with reduced susceptibility to polymyxin B
D Landman et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Multidrug-resistant Pseudomonas aeruginosa in Brooklyn, New York:: molecular epidemiology and in vitro activity of polymyxin B
S Bratu et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2005)
Reliability of the E-test method for detection of colistin resistance in clinical isolates of Acinetobacter baumannii
LA Arroyo et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Polymyxin B: An ode to an old antidote for endotoxic shock
VM Bhor et al.
MOLECULAR BIOSYSTEMS (2005)
Use of intravenous polymyxin B during continuous venovenous hemodialysis
JC Sarria et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2004)
In vitro double and triple synergistic activities of polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumannii
J Yoon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections
ME Sobieszczyk et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Pitfalls of polymyxin antimicrobial susceptibility testing of Pseudomonas aeruginosa isolated from cystic fibrosis patients
M Hogardt et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa
JB McPhee et al.
MOLECULAR MICROBIOLOGY (2003)
Polymyxin B nephrotoxicity and efficacy against nosocomial infections caused by multiresistant gram-negative bacteria
JP Ouderkirk et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Enhanced activity of liposomal polymyxin B against Pseudomonas aeruginosa in a rat model of lung infection
A Omri et al.
BIOCHEMICAL PHARMACOLOGY (2002)
Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: Review of available interpretative criteria and quality control guidelines
AC Gales et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2001)
Liquid chromatography of polymyxin B sulphate
JA Orwa et al.
JOURNAL OF CHROMATOGRAPHY A (2000)
Share Paper
